Key facts
- This page summarizes Bakker Juliet Tammenoms's Form 4 filing for RxSight, Inc. (RXST).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Jun 2026, 16:06.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
Additional SEC filing notes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
Footnote F2
Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.
Footnote F3
These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
SEC remarks
Exhibit 24 - Power of Attorney